Entirely new (smaller, thus more engineerable) Cas systems (1 month ago): http://www.nature.com/cr/journal/v27/n3/full/cr201721a.html
Variously engineered Cas9 proteins to reduce toxicity the over wild-type protein (two months ago): https://www.ncbi.nlm.nih.gov/pubmed/28179977
Cas9-Inhibitors to help regulate activity (two months ago) http://www.cell.com/cell/fulltext/S0092-8674(16)31683-X
And this doesn't include any ongoing research using other homing nuclease technologies like TALENs and Zn-Fingers that provide an entirely different set of tradeoffs but aren't as sexy, in part because they're harder to use.
Also, I think if they were serious about addressing this toxicity issue they would be include simple charts of the number of cells over time and number of "modified" cells over time. Then they (and the reader) can easily compare the toxicity and efficacy of different techniques.